Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLN · Real-Time Price · USD
29.76
-0.52 (-1.72%)
Nov 16, 2026, 4:00 PM EST - Market closed

Avalyn Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
1,325--
Market Cap Growth
---
Enterprise Value
955--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Debt / Equity Ratio
0.050.01-
Net Debt / Equity Ratio
-1.00-1.02-1.02
Net Debt / EBITDA Ratio
3.151.502.12
Net Debt / FCF Ratio
3.441.672.44
Quick Ratio
25.409.8612.72
Current Ratio
25.7610.1913.08
Return on Equity (ROE)
--68.34%-
Return on Assets (ROA)
--41.74%-
Return on Capital Employed (ROCE)
-30.50%-67.70%-48.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Buyback Yield / Dilution
-7020.43%-259.46%-
SEC Filings: 10-K · 10-Q